2seventy bio Announces Strategic Restructuring to Prioritize Growth of Abecma, Streamline Pipeline Advancement and Preserve Financial Runway
Approximately 40% workforce reduction combined with related actions expected to achieve $130+ million savings in the 2024-2025 period; projected cash runway into at least 2026 to support focus on...
Nick Leschly Company Board Of Directors Jw Therapeutics Partnership Expansion Chip Baird Restructure Actions Pipeline Portfolio
Source: marketscreener.com